Marek C Chawarski
Overview
Explore the profile of Marek C Chawarski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1693
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu T, Ryan D, Cadet T, Chawarski M, Coupet E, Edelman E, et al.
Ann Emerg Med
. 2024 Nov;
85(3):205-213.
PMID: 39570250
Study Objective(s): To evaluate the cost-effectiveness of implementation facilitation compared with a standard educational strategy to promote emergency department (ED)-initiated buprenorphine with linkage to ongoing opioid use disorder care in...
2.
Karunakaran T, Vicknasingam B, Chawarski M
Nat Prod Res
. 2024 Jun;
:1-8.
PMID: 38842220
, also known as kratom, has been reported to have a broad range of pharmacological properties. Freshly harvested leaves and their water extracts are consumed in Southeast Asia while preparations...
3.
Vicknasingam B, Karunakaran T, Chawarski M
Curr Opin Psychiatry
. 2024 May;
37(4):282-291.
PMID: 38818826
Purpose Of Review: Kratom plant, products derived from the plant, and plant phytochemicals are of great interest among researchers, clinicians, and consumers. However, there is a paucity of rigorously collected...
4.
Hassan Z, Singh D, Suhaimi F, Chear N, Harun N, See C, et al.
Regul Toxicol Pharmacol
. 2023 Aug;
143:105466.
PMID: 37536550
Mitragyna speciosa Korth also known as kratom, is an herbal drug preparation for its therapeutic properties and opioid-replacement therapy. Kratom is consumed in a brewed decoction form in Malaysia and...
5.
Henningfield J, Chawarski M, Garcia-Romeu A, Grundmann O, Harun N, Hassan Z, et al.
Drug Alcohol Depend Rep
. 2023 Jul;
7:100142.
PMID: 37397437
No abstract available.
6.
DOnofrio G, Edelman E, Hawk K, Chawarski M, Pantalon M, Owens P, et al.
JAMA Netw Open
. 2023 Apr;
6(4):e235439.
PMID: 37017967
Importance: Emergency department (ED)-initiated buprenorphine for the treatment of opioid use disorder (OUD) is underused. Objective: To evaluate whether provision of ED-initiated buprenorphine with referral for OUD increased after implementation...
7.
Mat N, Bakar S, Murugaiyah V, Chawarski M, Hassan Z
Behav Brain Res
. 2022 Dec;
439:114251.
PMID: 36503042
Mitragynine exerts its analgesic effect mainly via opioid receptors activation. Additionally, the effect may be mediated via mitragynine's anti-inflammatory property and non-opioid receptor pain pathways, namely through the TRPV1 receptor....
8.
Lyons M, Chawarski M, Rothman R, Whiteside L, Cowan E, Richardson L, et al.
J Addict Med
. 2022 Sep;
17(2):210-214.
PMID: 36170184
Objective: We assessed the frequency of emergency department (ED) HIV and hepatitis C (HCV) screening in a high-risk cohort of ED patients with untreated opioid use disorder (OUD). Methods: This...
9.
Vicknasingam B, Mohd Salleh N, Ramadah R, Singh D, Kamarulzaman A, Chawarski M
Int J Drug Policy
. 2021 Jun;
97:103311.
PMID: 34111680
No abstract available.
10.
Vicknasingam B, Mohd Salleh N, Chooi W, Singh D, Mohd Zaharim N, Kamarulzaman A, et al.
Front Psychiatry
. 2021 Apr;
12:630730.
PMID: 33854449
Restrictive orders and temporary programmatic or changes within healthcare and other supportive systems that were implemented in response to the COVID-19 epidemic in Malaysia may have created hindrances to accessing...